First Procedure in Asia-Pacific Performed with Medtronic Hugo(TM) Robotic-Assisted Surgery System
The Robotic Prostatectomy Took Place at Apollo Hospitals, Greams Road, Chennai, India DUBLIN and CHENNAI, India, Sept. 27, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT) and Apollo Hospitals Group today announced the first c... Devices, Surgery Medtronic, Hugo RAS system, robotic-assisted surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 27, 2021 Category: Pharmaceuticals Source Type: news

German Feasibility Study Shows Cerenkov Luminescence Imaging May Provide New Technique for Identifying Positive Margins during Prostatectomies
Prostate cancer currently has the highest positive surgical margin rate of any cancer in men, with 21% of patients left with cancer cells at the resection site Cancer surgeons may soon have a new technology to help them completely remove cancerous tissue during prostate cancer surgery. Called Cerenkov luminescence imaging (CLI), this new diagnostic technology […] The post German Feasibility Study Shows Cerenkov Luminescence Imaging May Provide New Technique for Identifying Positive Margins during Prostatectomies appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - September 20, 2021 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Coding, Billing, and Collections Compliance, Legal, and Malpractice Laboratory News Laboratory Pathology Laboratory Testing Managed Care Contracts & Payer Reimbursement anatomic pathology Boris A. Hadaschik PhD Cerenkov luminescence imagin Source Type: news

Fear of Recurrence Persists for Some Prostate Cancer Survivors
FRIDAY, Aug. 27, 2021 -- For prostate cancer survivors after radical prostatectomy, fear of cancer recurrence (FCR) remains a burden, even years after diagnosis, according to a study published online Aug. 6 in Cancer. Valentin H. Meissner, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 27, 2021 Category: Pharmaceuticals Source Type: news

' Routine' Use of Focal Therapy for Prostate Cancer in Next 5 Years'Routine' Use of Focal Therapy for Prostate Cancer in Next 5 Years
Focal therapy offers an alternative to prostatectomy for some men with early-stage prostate cancer. This approach will become routine in the near future, says a trio of physicians.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - August 6, 2021 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news

Prostate Cancer Surgery Lagged for Black Men During Pandemic
Black men less likely than White men to undergo prostatectomy despite similar COVID - 19 risk factors, biopsy Gleason grade groups (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 26, 2021 Category: Cancer & Oncology Tags: Oncology, Surgery, Urology, Journal, Source Type: news

Prostate cancer treatment among black, white patients during pandemic
This study included 647 patients with untreated nonmetastatic prostate cancer (269 patients during the pandemic and 378 from before the pandemic). During the initial COVID-19 lockdown, only 1% of Black men underwent prostatectomy, while 26% of white patients did. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 22, 2021 Category: Infectious Diseases Source Type: news

First Procedure in the World with Medtronic Hugo(TM) Robotic-Assisted Surgery System Performed at Clínica Santa Maria in Chile
The Robotic Prostatectomy Marked the Start of the Hugo™ RAS System Global Patient Registry DUBLIN, June 22, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first p... Devices, Surgery Medtronic, Hugo RAS system, robotic-assisted surgery, robotic surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2021 Category: Pharmaceuticals Source Type: news

Adjuvant RT May Aid Men at High Risk for Death From Prostate Cancer
Adjuvant RT versus early salvage RT may lower the risk for all - cause mortality in men with adverse pathology at radical prostatectomy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 16, 2021 Category: Cancer & Oncology Tags: Oncology, Pathology, Radiology, Surgery, Urology, Journal, Source Type: news

Radical Prostatectomy Shifting to Higher-Risk Cases in Era of Active Surveillance Radical Prostatectomy Shifting to Higher-Risk Cases in Era of Active Surveillance
There has been a trend towards increasing use of radical prostatectomy in men with unfavorable-intermediate- and high-risk disease, according to a time-trends analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 16, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Adjuvant RT May Aid Men at High Risk for Death From Prostate Cancer
WEDNESDAY, June 16, 2021 -- For men with positive pelvic lymph nodes (pN1) or pGleason score 8 to 10 prostate cancer and disease extending beyond the prostate (pT3/4) at radical prostatectomy (RP), adjuvant radiation therapy (RT) versus early... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 16, 2021 Category: Pharmaceuticals Source Type: news

Pelvic Strength Helps Determine When Continence Returns After Radical Prostatectomy Pelvic Strength Helps Determine When Continence Returns After Radical Prostatectomy
Assessment of pelvic-floor strength before radical prostatectomy may allow for more accurate prediction of early return of continence after surgery, new research indicates.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 1, 2021 Category: Surgery Tags: Urology News Source Type: news

New device helps restore penile length and sexual function after prostate cancer surgery
(Wolters Kluwer Health) A new type of penile traction therapy (PTT) device can increase penile length and preserve erectile function in men who have undergone prostate cancer surgery (prostatectomy), reports a clinical trial in The Journal of Urology ® , Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 1, 2021 Category: International Medicine & Public Health Source Type: news

Einstein Researchers Develop Novel Drug That Regenerates Erectile Nerves Damaged by Prostate Surgery
April 19, 2021—(BRONX, NY)—Researchers atAlbert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer. The drug was tested in rats, and the findings were published online today inJCI Insight. (Source: Einstein News)
Source: Einstein News - April 19, 2021 Category: Universities & Medical Training Source Type: news

Novel drug regenerates erectile nerves damaged by prostate surgery
(Albert Einstein College of Medicine) Researchers at Albert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer. The drug was tested in rats, and the findings were published online today in JCI Insight. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 19, 2021 Category: Cancer & Oncology Source Type: news

Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU
February 2, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it will highlight the depth of its solid tumor portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium with 12 data presentations, including three company-sponsored oral presentations from the ERLEADA® (apalutamide) clinical development program. The virtual meeting will take place February 11-13, 2021. “We are committed to the development of innovative therapies for patients with genitourinary cancers for whom there remains a high unmet need,” said C...
Source: Johnson and Johnson - February 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Postprostatectomy Urinary Outcomes Vary Widely by Patient and Surgeon Postprostatectomy Urinary Outcomes Vary Widely by Patient and Surgeon
Patient-reported urinary outcomes three months after radical prostatectomy vary by patient and by surgeon, and a new study suggests that outcomes may be better with top-performing surgeons.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 28, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

What to Expect After Prostate Is Removed
What Is the Difference Between Prostatectomy vs. Radical Prostatectomy? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 25, 2021 Category: General Medicine Source Type: news

What to Expect Prostate Removal Prostatectomy
What to Expect After Prostate Removal (Prostatectomy) (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 11, 2021 Category: General Medicine Source Type: news

Comparisons of Analgesic Efficacy in Laparoscopic Prostatectomy Comparisons of Analgesic Efficacy in Laparoscopic Prostatectomy
This study compared postoperative analgesic outcomes of three commonly used anesthesia techniques in patients undergoing robot-assisted laparoscopic prostatectomy.BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 22, 2020 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Prostate Cancer Pathology Not Worse With Delayed Surgery
Delayed radical prostatectomy not linked to higher risk for adverse pathological outcomes in high - risk prostate cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 11, 2020 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Oncology, Pathology, Surgery, Journal, Source Type: news

Prostate Cancer Pathology Not Worse With Delayed Surgery
FRIDAY, Dec. 11, 2020 -- Among men with clinically localized high-risk prostate adenocarcinoma undergoing radical prostatectomy, surgical delay time (SDT) is not associated with a higher risk for adverse pathological features or with worse overall... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2020 Category: Pharmaceuticals Source Type: news

Safety of delaying surgery for high-risk prostate cancer
(JAMA Network) Considering   when health care resources need to be prioritized during special times, such as the COVID-19 pandemic, researchers in this observational study   looked at whether delaying radical prostatectomy surgery for up to six months for high-risk prostate cancer was associated with worse outcomes. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 8, 2020 Category: Infectious Diseases Source Type: news

UCLA, UCSF gain FDA approval for prostate cancer imaging technique
The University of California ’s two nationally ranked medical centers, UCSF and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the t umors have migrated.Known as prostate-specific membrane  antigen PET imaging, or PSMA PET, the technique uses positron emission tomography in conjunction with a PET-sensitive drug that is highly effective in detecting prostate cancer throughout the body so that it can be better and mor...
Source: UCLA Newsroom: Health Sciences - December 1, 2020 Category: Universities & Medical Training Source Type: news

Urethral-sparing Robot-Assisted Simple Prostatectomy Preserves Ejaculatory Function Urethral-sparing Robot-Assisted Simple Prostatectomy Preserves Ejaculatory Function
Urethral-sparing robot-assisted simple prostatectomy (usRASP) preserves ejaculatory function while relieving lower-urinary-tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), according to findings from a prospective study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 20, 2020 Category: Surgery Tags: Urology News Source Type: news

Main Line physician enlists robot used by Boeing and SpaceX to help patients battle baldness
While robot-assisted surgery systems are probably best known for helping with delicate procedures such as mitral valve repairs and prostatectomies, Dr. Andrew Kwak is using a robot for another type of procedure. Kwak, founder of The Lumen Center, said his Main Line practice is the first in the Philadelphia area to have a robotic hair transplant system. Last month, the practice purchased and installed the ARTAS iX robotic hair restoration system. Kwak, a cosmetic surgeon who specializes in minimally… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 12, 2020 Category: Biotechnology Authors: John George Source Type: news

Hood Technique Can Facilitate Swift Return to Urinary Continence After Radical Prostatectomy Hood Technique Can Facilitate Swift Return to Urinary Continence After Radical Prostatectomy
The'hood'technique for robot-assisted prostatectomy enabled a return to continence within four months, without compromising surgical margins, in a single-center, single-surgeon study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - October 28, 2020 Category: Surgery Tags: Urology News Source Type: news

MFS Is a strong surrogate endpoint for OS for men receiving salvage RT for recurrent prostate cancer
(NRG Oncology) An analysis of the phase III NRG Oncology clinical trial RTOG 9601 on men receiving salvage radiotherapy (SRT) following prostatectomy for recurrent prostate cancer indicated that, while biochemical failure (BF) was not a strong surrogate endpoint to determine overall survival (OS), metastasis-free survival (MFS) was in this patient population. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 26, 2020 Category: Cancer & Oncology Source Type: news

Cerenkov luminescence imaging identifies surgical margin status in radical prostatectomy
(Society of Nuclear Medicine and Molecular Imaging) A new intraoperative imaging technique, Cerenkov luminescence imaging (CLI), can accurately assess surgical margins during radical prostatectomy, according to a first-in-human research published in the October issue of The Journal of Nuclear Medicine. The feasibility study showed that 68Ga-PSMA CLI can image the entire excised prostate specimen's surface to detect prostate cancer tissue at the resection margin. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 7, 2020 Category: Cancer & Oncology Source Type: news

Adjuvant Radiotherapy No Better for Localized Prostate Cancer
MONDAY, Oct. 5, 2020 -- Adjuvant radiotherapy does not improve event-free survival in men with localized or locally advanced prostate cancer treated with radical prostatectomy, according to a review and meta-analysis published online Sept. 28 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 5, 2020 Category: Pharmaceuticals Source Type: news

Mayo Clinic Q and A: Advances in ablation for prostate cancer
DEAR MAYO CLINIC: My husband was diagnosed with prostate cancer, and we are looking at treatment options. One doctor suggested a prostatectomy, but my husband finds ablation appealing because of quality of life advantages. I've been reading about ablations and came across information about different techniques. I am wondering if one technique or process is better, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 30, 2020 Category: Databases & Libraries Source Type: news

Hold Off Radiotherapy After Prostate Cancer Surgery Hold Off Radiotherapy After Prostate Cancer Surgery
Instead of adjuvant radiotherapy after prostatectomy, observation and early salvage radiotherapy offer equal outcomes with fewer side effects.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - September 29, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Versius surgical robotic system launched in France
The robotic technology will be used to conduct procedures such as hernia repair surgeries, prostatectomies and hysterectomies. (Source: mobihealthnews)
Source: mobihealthnews - September 21, 2020 Category: Information Technology Source Type: news

Sugammadex vs. Neostigmine in Laparoscopic Prostatectomy Sugammadex vs. Neostigmine in Laparoscopic Prostatectomy
Can sugammadex reduce the length of hospital stay, recovery time, and unplanned readmission for patients who underwent robot-assisted laparoscopic prostatectomy when compared to neostigmine?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 17, 2020 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Better Continence Rate Gives Robotic Prostatectomy the Edge Better Continence Rate Gives Robotic Prostatectomy the Edge
Rates of urinary continence were higher after robot-assisted radical prostatectomy than after laparoscopic radical prostatectomy in a large-scale, randomized comparison of the two approaches.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - August 5, 2020 Category: Surgery Tags: Urology News Source Type: news

Roche ’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpoints
      ·Phase III IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone compared to current standard-of-care (abiraterone and prednisone/prednisolone alone) plus placebo met its co-primary endpoint of radiographic progression free survival (rPFS) in patients with PTEN loss tumoursBasel, 19 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the phase III IPATential150 study met its co-primary endpoint of radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCR...
Source: Roche Media News - June 19, 2020 Category: Pharmaceuticals Source Type: news

Genomic Prostate Score Does Not Improve Risk Assessment Genomic Prostate Score Does Not Improve Risk Assessment
A genomic prostate score has little value in predicting adverse outcomes in men who have undergone a period of active surveillance before having a radical prostatectomy, according to a study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 25, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NCCN Guidelines Designate Decipher Prostate as "Recommended" for Men with Adverse Pathology after Radical Prostatectomy
The first and only genomic test to achieve "Recommended" status for the management of prostate cancer patients SAN DIEGO, March 24, 2020 -- (Healthcare Sales & Marketing Network) -- Decipher Biosciences, a commercial-stage precision oncology ... Diagnostics, Urology, Oncology Decipher Biosciences, Decipher Prostate RP, prostate cancer, NCCN (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 24, 2020 Category: Pharmaceuticals Source Type: news

Prostatectomy, Radiotherapy Effective Primary Treatments for Prostate Cancer Prostatectomy, Radiotherapy Effective Primary Treatments for Prostate Cancer
Radical prostatectomy (RP) and radiotherapy (RT) are good primary treatment options for men with high-risk localized and locally advanced prostate cancer, according to a systematic review.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 19, 2020 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Web-Based Tool Helps Predict Functional Outcomes After Prostate Cancer Treatment Web-Based Tool Helps Predict Functional Outcomes After Prostate Cancer Treatment
A web-based tool can help predict functional outcomes for five years after treatment of localized prostate cancer with radical prostatectomy (RP), intensity-modulated radiation therapy (RT), or active surveillance, researchers say.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 18, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Prostatectomy of Mixed Mortality Benefit in Men With Cancer Prostatectomy of Mixed Mortality Benefit in Men With Cancer
Over decades, death from any cause is lower in some men who undergo radical prostatectomy but observation alone may be a better choice in others with prostate cancer, according to a long-term follow-up of a randomized trial.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 12, 2020 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Surgical Approach Not Tied to Decision Regret After Prostatectomy
Functional and oncologic outcomes, autonomous decision - making, and follow - up time influence regret (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 3, 2020 Category: Cancer & Oncology Tags: Oncology, Surgery, Urology, Journal, Source Type: news

Surgical Approach Not Tied to Decision Regret After Prostatectomy
TUESDAY, March 3, 2020 -- Surgical approach is not associated with intermediate-term decision regret following radical prostatectomy, according to a study published in the March issue of The Journal of Urology. Martin Baunacke, M.D., from Technische... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 3, 2020 Category: Pharmaceuticals Source Type: news

Low Rates of Regret After Prostatectomy When Outcomes Are Good Low Rates of Regret After Prostatectomy When Outcomes Are Good
Patients are satisfied after either open or robot-assisted surgery, provided functional outcomes are good, an observational study reports.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 20, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Minimally Invasive Surgery Through the Eyes of a Surgeon
One of the best parts of an event like MD&M West is the opportunity to put a cross-section of experts from industry in the same room as engineers and end-users and talk about the biggest trends in medical devices. One such discussion that took place here in Annaheim, CA on Tuesday included an expert robotic surgeon, an expert from Intuitive Sugical (which, as you likely know by now, pioneered robotic surgery a little more than 20 years ago), and a new robotic surgery company that is trying to to take this technology beyond the surgical suite. I shared a few insights from this lively panel discussion here, but prior to...
Source: MDDI - February 11, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Stress Urinary Incontinence Post-Prostatectomy May Lead to Pelvic Floor Overactivity
This study suggested that along with pelvic floor underactivity, men who had a prostatectomy and experienced stress urinary incontinence as a result have pelvic floor overactivity as well. (Source: CancerNetwork)
Source: CancerNetwork - January 28, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Tailored Pelvic PT May Curb Post-Prostatectomy Stress Incontinence, Pain Tailored Pelvic PT May Curb Post-Prostatectomy Stress Incontinence, Pain
After prostate surgery, individualized pelvic physical therapy to relax or strengthen the pelvic muscles may be more effective for reducing stress urinary incontinence (SUI) and pelvic pain than muscle strengthening alone, researchers suggest.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 13, 2020 Category: Consumer Health News Tags: Urology News Source Type: news

Prostate Cancer Treatment: Radical Prostatectomy Surgery
Title: Prostate Cancer Treatment: Radical Prostatectomy SurgeryCategory: Diseases and ConditionsCreated: 1/9/2020 12:00:00 AMLast Editorial Review: 1/9/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 9, 2020 Category: Cancer & Oncology Source Type: news

Individualized PT Can Reduce Incontinence After Prostatectomy
FRIDAY, Jan. 3, 2020 -- For men with postprostatectomy stress urinary incontinence (SUI), an individualized pelvic physical therapy (PT) program aimed at normalizing pelvic floor dysfunction (PFD) is associated with a decrease in SUI and pelvic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 3, 2020 Category: Pharmaceuticals Source Type: news

Prostate Cancer Genomic Classifier Appears Effective for Improved Patient Outcomes
When treatment decisions were made using a prostate genomic classifier after radical prostatectomy in men with prostate cancer, patient outcomes significantly improved. (Source: CancerNetwork)
Source: CancerNetwork - December 31, 2019 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news